Vivo Opportunity Fund Holdings, L.P. - 30 Jun 2025 SCHEDULE 13G/A Report for Soleno Therapeutics, Inc. Common Stock, $0.001 par value per share (SLNO)

Filing Manager: Vivo Opportunity Fund Holdings, L.P.
Reporting Manager: Vivo Opportunity Fund Holdings, L.P.
Security: Soleno Therapeutics, Inc. Common Stock, $0.001 par value per share
Symbol: SLNO
Shares outstanding: 53,490,459 shares
Disclosed Ownership: 3,958,294 shares
Ownership: 7.4%
Form type: SCHEDULE 13G/A
Filing time: 12 Aug 2025, 20:52:20 UTC
Date of event: 30 Jun 2025
Previous filing: 31 Mar 2025
Next filing: 14 Nov 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Vivo Opportunity Fund Holdings, L.P.	7.4%	3,958,294	3,958,294	0	/s/ Kevin Dai	Kevin Dai/Managing Member
Vivo Opportunity, LLC	7.4%	3,958,294	3,958,294	0	/s/ Kevin Dai	Kevin Dai/Managing Member